Diabetes in South Asians

Diabetic Medicine

Volumn 31, Issue 10, 2014, Pages 1153-1162

  Misra, Anoop ^a,b,c   Ramchandran, A ^d,e   Jayawardena, R ^f,g   Shrivastava, U ^b,c   Snehalatha, C ^d,e  

^a Fortis C DOC Centre of Excellence for Diabetes Metabolic Diseases and Endocrinology   (India)

^b Diabetes Foundation (India)   (India)

^c Obesity and Cholesterol Diseases Foundation N DOC   (India)

^d India Diabetes Research Foundation   (India)

^e Dr A Ramachandran's Diabetes Hospitals   (India)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^g UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; FAT; INSULIN; METFORMIN; MINERAL; PIOGLITAZONE; VITAMIN;

ABDOMINAL OBESITY; AWARENESS; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIETARY INTAKE; EARLY DIAGNOSIS; FRUIT VEGETABLE; HEALTH CARE ACCESS; HEALTH PROGRAM; HEREDITY; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MIGRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; REVIEW; SCREENING TEST; SOCIAL STATUS; SOUTH ASIAN; URBAN AREA; ASIA; DIABETES MELLITUS, TYPE 2; ETHNOLOGY; HEALTH; HEALTH PROMOTION; MULTIMODALITY CANCER THERAPY; POPULATION DYNAMICS;

ASIA; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; HEALTH PROMOTION; HEALTH TRANSITION; HUMANS; PREVALENCE; RURAL HEALTH; URBAN HEALTH;

EID: 84919805227     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12540     Document Type: Review

References (51)

1. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA. Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J 1988; 60: 390-396.
2. International Diabetes Federation, ed. IDF Diabetes Atlas. 6th edn. Brussels: International Diabetes Federation, 2013.
3. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008; 31: 893-898.
4. Misra P, Upadhyay RP, Misra A, Anand K. A review of the epidemiology of diabetes in rural India. Diabetes Res Clin Pract 2011; 92: 303-311.
5. Magliano DJ, Soderberg S, Zimmet PZ, Chen L, Joonas N, Kowlessur S et al. Explaining the increase of diabetes prevalence and plasma glucose in Mauritius. Diabetes Care 2012; 35: 87-91.
6. Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health 2012; 12: 380.
7. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49: 289-297.
8. Katikireddi SV, Morling JR, Bhopal R. Is there a divergence in time trends in the prevalence of impaired glucose tolerance and diabetes? A systematic review in South Asian populations. Int J Epidemiol 2011; 40: 1542-1553.
9. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes 2011; 35: 167-187.
10. Jenum AK, Diep LM, Holmboe-Ottesen G, Holme IM, Kumar BN, Birkeland KI. Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women. BMC Public Health 2012; 12: 150.
11. Ramachandran A, Snehalatha C, Viswanathan V, Viswanathan M, Haffner SM. Risk of non-insulin-dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract 1997; 36: 121-125.
12. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-30.
13. Chandie Shaw PK, Baboe F, van Es LA, van der Vijver JC, van de Ree MA, de Jonge N et al. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care 2006; 29: 1383-1385.
14. Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrients 2013; 5: 2708-2733.
15. Misra A, Khurana L, Isharwal S, Bhardwaj S. South Asian diets and insulin resistance. Br J Nutr 2009; 101: 465-473.
16. Sevak L, McKeigue PM, Marmot MG. Relationship of hyperinsulinemia to dietary intake in South Asian and European men. Am J Clin Nutr 1994; 59: 1069-1074.
17. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006; 124: 235-244.
18. Misra A, Sharma R, Gulati S, Joshi SR, Sharma V, Ghafoorunissa et al. National Dietary Guidelines Consensus Group. Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians. Diabetes Technol Ther 2011; 13: 683-694.
19. Misra A, Alappan NK, Vikram NK, Goel K, Gupta N, Mittal K et al. Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes. Diabetes Care 2008; 31: 1282-1287.
20. Misra A, Nigam P, Hills AP, Chadha DS, Sharma V, Deepak KK et al. Physical Activity Consensus Group. Consensus physical activity guidelines for Asian Indians. Diabetes Technol Ther 2012; 14: 83-98.
21. Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH. Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med 2005; 20: 474-478.
22. Hayes L, White M, Unwin N, Bhopal R, Fischbacher C, Harland J et al. Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population. J Public Health Med 2002; 24: 170-178.
23. Lean ME, Han TS, Bush H, Anderson AS, Bradby H, Williams R. Ethnic differences in anthropometric and lifestyle measures related to coronary heart disease risk between South Asian, Italian and general-population British women living in the west of Scotland. Int J Obes Relat Metab Disord 2001; 25: 1800-1805.
24. Shaukat N, Douglas JT, Bennett JL, de Bono DP. Can physical activity explain the differences in insulin levels and fibrinolytic activity between young Indo-origin and European relatives of patients with coronary artery disease? Fibrinolysis 1995; 9: 55-63.
25. Rudat K. Black and Minority Ethnic Groups in England: Health and Lifestyles. London: Health Education Authority, 1994. Available at www.nice.org.uk/nicemedia/documents/black_minorities_ england94.pdf Last accessed 14 January 2014.
26. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009; 57: 163-170.
27. NICE. Assessing Body Mass Index and Waist Circumference Thresholds for Intervening to Prevent Ill Health and Premature Death among Adults from Black, Asian and Other Minority Ethnic Groups in the UK. London: National Institute for Health and Care Excellence, 2013.
28. WHO. How do we define obesity and overweight? In: Obesity and Overweight. Available at http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf Last accessed 17 January 2014.
29. IDF. IDF Worldwide Definition of the Metabolic Syndrome. Brussels: International Diabetes Federation, 2013. Available at https://www.idf.org/metabolic-syndrome Last accessed 21 January 2014.
30. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
31. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011; 43: 984-989.
32. Bhatt SP, Nigam P, Misra A, Guleria R, Luthra K, Jain SK et al. Association of the myostatin gene with obesity, abdominal obesity and low lean body mass and in non-diabetic Asian Indians in north India. PLoS One 2012; 7: e40977.
33. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
34. Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 2004; 134: 205-210.
35. Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition 2007; 23: 696-708.
36. Balasuriya BMAC, Sumanatilleke MR, Jayasekera TI, Wijesuriya MA, Somasundaram NP. Prevalence of micro- and macrovascular complications of diabetes detected at single visit screening. Sri Lanka J Diabetes Endocrinol Metab 2012; 2: 17-20.
37. Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, Bellary S et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 2009; 32: 410-415.
38. Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura A et al. Enhanced diabetes care to patients of South Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet 2008; 371: 1769-1776.
39. Earle KK, Porter KA, Ostberg J, Yudkin JS. Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant 2001; 16: 286-290.
40. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, SheriffMH, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr 2012; 4: 21.
41. Viswanathan V, Madhavan S, Rajasekar S, Chamukuttan S, Ambady R. Urban-rural differences in the prevalence of foot complications in South-Indian diabetic patients. Diabetes Care 2006; 29: 701-703.
42. Wilkinson P, Sayer J, Laji K, Grundy C, Marchant B, Kopelman P et al. Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ 1996; 312: 1330-1333.
43. Mu YM, Misra A, Adam JM, Chan SP, Chow FC, Cunanan EC et al. Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Res Clin Pract 2012; 95: 179-188.
44. Raji A, Gerhard-Herman MD, Williams JS, O'Connor ME, Simonson DC. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. Diabet Med 2006; 23: 537-543.
45. Khunti K, Kumar S, Brodie J. Diabetes UK and South Asian Health Foundation Recommendations on Diabetes Research Priorities for British South Asians. London: Diabetes UK and South Asian Health Foundation, 2009.
46. Indian Council of Medical Research. Guidelines for Management of Type 2 Diabetes. New Delhi: Indian Council of Medical Research, 2005.
47. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention ormetformin. NEngl JMed 2002; 346: 393-403.
48. Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC et al. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia 2009; 52: 1019-1026.
49. Singhal N, Misra A, Shah P, Gulati S. Effects of controlled school-based multi-component model of nutrition and lifestyle interventions on behavior modification, anthropometry and metabolic risk profile of urban Asian Indian adolescents in North India. Eur J Clin Nutr 2010; 64: 364-373.
50. Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2013; 1: 191-198.
51. Basu S, Vellakkal S, Agrawal S, Stuckler D, Popkin B, Ebrahim S et al. Averting obesity and Type 2 diabetes in India through sugar-sweetened beverage taxation: an economic-epidemiologic modeling study. PLoS Med 2014; 11: e1001582.